• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

Longbow et al. invest in Domainex

Longbow, The Capital Fund and Takeda Research Investment have invested an undisclosed amount of capital in biotechnology company Domainex.

  • Early-stage
  • 24 February 2010
Siemens hearing aids sale might be cancelled

According to reports, the sale of Siemens Audiologische Technik, the hearing aids business of Siemens AG, might not go through.

  • Buyout
  • 23 February 2010
3i makes 3.5x money on Ambea sale to Triton

3i has divested its stake in healthcare and care services provider Ambea in a €850m secondary buyout to Triton.

  • Exits
  • 23 February 2010
Novartis Ventures et al. in £8.65m round for ITS

Novartis Ventures, Sweden’s HealthCap, France’s Truffle Capital and London Technology Fund, have participated in a £8.65m funding round for British biotech company Immune Targeting Systems (ITS).

  • Healthcare
  • 17 February 2010
bart-diels-gimv
Q&A: Early-stage evolution

Bart Diels, partner at Belgian investor Gimv, speaks to Francinia Protti-Alvarez about how the venture market in the Benelux region has adapted to the changing economic climate.

  • GPs
  • 17 February 2010
EQT's Actavis still in the race for for ratiopharm

According to reports, EQT-backed Actavis is still left in the race for generic drugs group ratiopharm being sold by VEM Vermoegensverwaltung GmbH.

  • Buyouts
  • 16 February 2010
CapMan invests in Hermelinen

CapMan has invested the Swedish private health care centre Hermelinen.

  • Buyouts
  • 11 February 2010
Hygea et al invest £2.7m in Glide Pharma

Existing investors Hygea VCT and Oxford Technology VCT have further invested in drug company Glide Pharma as part of a £2.7m fourth round of funding, alongside Oxford Capital Partners and private backers.

  • Expansion
  • 11 February 2010
CRB’s OWL Genomics acquires 70% stake of MD Renal

Cross Road Biotech (CRB) portfolio company OWL Genomics has acquired a 70% stake in sector business MD Renal.

  • Southern Europe
  • 10 February 2010
Aescap-backed Biocartis acquires Philips Technology Platform

Aescap-backed molecular diagnostics company Biocartis has acquired Philips’ technology platform for rapid fully-automated DNA/RNA molecular diagnostic testing.

  • Portfolio management
  • 10 February 2010
medical-big-jpg
Volati acquires Team Ortopedteknik

Swedish buyout house Volati has acquired orthopaedic technology company Team Ortopedteknik

  • Buyouts
  • 09 February 2010
Waterland backed Medhold sold to Sonic Healthcare

Waterland Private Equity has divested its stake in Belgian laboratory business Medhold Group to Australian-based Sonic Healthcare who has fully acquired the business.

  • Exits
  • 08 February 2010
Longbow Capital launches £10m Approved EIS Fund

Longbow Capital has launched the Longbow Approved EIS Fund, a tax-efficient investment vehcile aimed at investment in the healthcare, life science and well-being sectors.

  • Venture
  • 08 February 2010
Young woman at graduation ceremony
Strong research bodes bright future for Dutch venture

The Netherlands’ excellence in the fields of ICT and Life Sciences is driving dealflow up and prompting optimism for the future. By Francinia Protti-Alvarez

  • Early-stage
  • 05 February 2010
Scottish Enterprise invests in Sistemic

Scottish Enterprise and ChimeraBio have led a series A funding round for biotech company Sistemic.

  • Early-stage
  • 04 February 2010
dna-strain-web
Exits hat-trick proves healthy appetite for life sciences

  • Healthcare
  • 04 February 2010
Oxford Capital launches fifth Approved EIS Fund

  • Venture
  • 04 February 2010
ramesh-jassal-web
Clearwater boosts healthcare team with new hire

Clearwater Corporate Finance has hired Ramesh Jassal to its healthcare team.

  • People
  • 03 February 2010
Argos Soditic reaps more than 4.5x on Dinno Santé exit

Argos Soditic, FHH Conseil and the management have sold their 100% stake in Dinno Santé to the healthcare business of Air Liquide and in doing so have realised over 4.5x return.

  • Exits
  • 02 February 2010
BioMedPartners strengthens management team

Healthcare venture firm BioMedPartners has strengthened its management with Josef Bissig as new venture partner.

  • People
  • 02 February 2010
LSP in €21.7m series B round for Merus

Life Sciences Partners (LSP), Novartis Option Fund, Pfizer and Bay City Capital have co-led a €21.7m series B financing round for biopharmaceutical Merus.

  • Early-stage
  • 29 January 2010
Rainbow Seed Fund et al invest £2m into Microvisk

Existing investor the Rainbow Seed Fund, alongside Oxford Technology Management, the Advantage Growth Fund, Finance Wales and New Hill, have invested £2m into medical diagnostic company Microvisk Technologies.

  • Early-stage
  • 28 January 2010
Healthcare: the sector to watch

A seemingly recession-resilient sector attracts capital in the downturn. By Deborah Sterescu

  • Investments
  • 25 January 2010
CZECH/POLAND - ARX backs opthamology bolt-on

CEE GP ARX Equity Partners has backed its Czech portfolio company Lexum Group in its acquisition of Intermedica, a private Polish opthamology chain.

  • Expansion
  • 21 January 2010
126 127 128
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013